Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.
Press releases published on April 21, 2025
Futurum Gaming Announces Flagship Game Launch, Genesis NFT Mint, and Token Generation Event
GlobeNewswire
·
April 21, 2025
STAFFORDSHIRE, England, April 21, 2025 (GLOBE NEWSWIRE) -- Futurum Gaming has announced the official launch of its debut Web3 title, Race to Infinity, alongside the minting of its Genesis NFT collection and the forthcoming Token Generation Event (TGE) …
Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts
GlobeNewswire
·
April 21, 2025
Vancouver, Canada, April 21, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
XRP Settlement Spurs Cloud Mining Innovation – JA Mining Introduces Mining Utility for Token Holders
GlobeNewswire
·
April 21, 2025
WARWICK, United Kingdom, April 21, 2025 (GLOBE NEWSWIRE) -- In the cryptocurrency space, XRP is emerging with impressive momentum. In early 2025, its price experienced significant growth, reaching a high of $3.39. At the same time, Ripple's legal dispute …
Enlivex Announces Completion of Enrollment In The Phase II stage Of Its Phase I/II Trial Evaluating Allocetra In Patients With Moderate To Severe Knee Osteoarthritis
GlobeNewswire
·
April 21, 2025
Nes-Ziona, Israel, April 21, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the Company completed enrollment of all patients in the …
ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
GlobeNewswire
·
April 21, 2025
MADRID and CAMBRIDGE, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that the European Patent Office has …
Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP
GlobeNewswire
·
April 21, 2025
BRISBANE, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the U.S. Food …
Reflect Scientific Inc. Announces Strategic Market Transition and Substantial Cost Savings
GlobeNewswire
·
April 21, 2025
OREM, Utah, April 21, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific Inc. (symbol: RSCF), a leading innovator in advanced refrigeration and cooling technologies, today announced significant financial improvements resulting from strategic market transitions …
Taseko Provides Construction Update on Florence Copper Project
GlobeNewswire
·
April 21, 2025
VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) ("Taseko" or the "Company") is pleased to update the progress at its 100%-owned Florence Copper project in Florence, Arizona. …
American Tungsten Corp. to Participate at Top Shelf Partners Commodities Global Expo 2025
GlobeNewswire
·
April 21, 2025
Vancouver, BC, April 21, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce its attendance and participation at Top Shelf Partners Commodities Global Expo 2025. …
Invivyd Announces $30M Non-dilutive Loan Facility with Silicon Valley Bank
GlobeNewswire
·
April 21, 2025
WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it has signed a $30 million term loan facility with …
Arvinas to Present Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at 2025 American Association for Cancer Research® (AACR) Annual Meeting
GlobeNewswire
·
April 21, 2025
NEW HAVEN, Conn., April 21, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that new preclinical combination data …
BioCryst to Report First Quarter 2025 Financial Results on May 5
GlobeNewswire
·
April 21, 2025
RESEARCH TRIANGLE PARK, N.C., April 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2025 financial results on Monday, May 5, 2025. BioCryst management will host a …
AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
GlobeNewswire
·
April 21, 2025
LONDON and PHOENIX, Ariz., April 21, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele …
Apellis Announces Craig Wheeler to Join the Board of Directors
GlobeNewswire
·
April 21, 2025
WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that Craig Wheeler, founder and chief executive officer of Headwaters Biotech Advisors, will join the Apellis Board of Directors, effective …
Cryptocurrency has quietly become the preferred asset reserve for investment, and KSD Miner is very popular among users around the world.
GlobeNewswire
·
April 21, 2025
London, UK, April 21, 2025 (GLOBE NEWSWIRE) -- From Change to Big Cash: How to Make $1 Million with $100 in 2025 As times have changed, Will the US tariffs lead to a depreciation of the US dollar? Cryptocurrency has quietly become the preferred asset …
Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
GlobeNewswire
·
April 21, 2025
MANNHEIM, Germany, April 21, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it has received a written notice (the “ …
Alumis and ACELYRIN Announce Amended Merger Agreement
GlobeNewswire
·
April 21, 2025
ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company on a fully diluted basis Merger …
XRP News: XploraDEX Presale Enters Final Hours—$XPL Token Distribution Begins This Week as XRP’s Smartest DEX Goes Live
GlobeNewswire
·
April 21, 2025
ZURICH, April 21, 2025 (GLOBE NEWSWIRE) -- The clock is down to its final ticks. With just a few hours left before the XploraDEX $XPL Presale closes, the XRP community is witnessing a final rush of activity as investors make their last move to be part of …
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development
GlobeNewswire
·
April 21, 2025
VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …
Tumella Unveils the Strongest Folding Umbrella on the Market, Setting a New Standard for Durability
GlobeNewswire
·
April 21, 2025
Dordrecht, The Netherlands, April 21, 2025 (GLOBE NEWSWIRE) -- Just in time for spring showers, Tumella’s bestselling umbrella emerges as a must-have companion for the season even under extreme weather. Designed to endure wind speeds of over 70 miles per …